Adults' Acceptance of COVID-19 Vaccine for Children in Selected Lower- and Middle-Income Countries

Suzanna Awang Bono1, Ching Sin Siau2, Won Sun Chen3

  • 1School of Social Science, Universiti Sains Malaysia, Gelugor 11800, Malaysia.

Vaccines
|January 22, 2022
PubMed

Insights

Willingness to vaccinate children against COVID-19 in lower- and middle-income countries increases with vaccine effectiveness. Higher knowledge and fear of COVID-19 also correlate with greater parental acceptance of child vaccination.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Emergency use authorization for COVID-19 vaccines in adolescents has been granted in the US and Europe.
  • Assessing parental willingness to vaccinate children in lower- and middle-income countries (LMICs) is crucial for global vaccine rollout.

Purpose of the Study:

  • To evaluate the willingness of individuals in LMICs to vaccinate children against COVID-19.
  • To determine the relationship between vaccine effectiveness levels and vaccination willingness.
  • To identify factors influencing the acceptance of pediatric COVID-19 vaccination.

Main Methods:

  • An online cross-sectional survey was conducted across several LMICs.
  • Data collected included socio-demographics, COVID-19 knowledge, fear levels, and willingness to vaccinate children at varying effectiveness thresholds (50%, 75%, 95%).
  • Statistical analysis was performed on data from 6571 participants.

Main Results:

  • Willingness to vaccinate children increased significantly with higher vaccine effectiveness: 64.0% at 50%, 72.6% at 75%, and 92.9% at 95% effectiveness.
  • Factors positively associated with willingness included higher education (undergraduate), greater worry/fear of COVID-19, increased COVID-19 knowledge, and a stronger belief in the importance of vaccination for protecting others.
  • Participants were generally more willing to vaccinate children as perceived vaccine effectiveness increased.

Conclusions:

  • Pediatric COVID-19 vaccination willingness in LMICs is strongly influenced by perceived vaccine effectiveness, knowledge, and fear of the virus.
  • Higher acceptance rates are achievable with highly effective vaccines.
  • Findings can inform targeted health promotion strategies for child COVID-19 vaccination campaigns in LMICs, potentially reducing virus transmission in schools and mitigating negative impacts of school closures on child development.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17